CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company is headquartered in San Mateo, California.
Click "Analyze" to generate stock analysis
CRGX Price Trend and Signals
CRGX Option Volumes & Open Interests (aggregated)
CRGX Put Call Ratios and IV (aggregated)
2025-08-18Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-08-18Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-08-18Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-08-18Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.